CatalYm (private company)
See something wrong or missing? Let us know
Offices:Munich
Industry:BiotechHealth servicesManufacturing
Business model:B2B
CatalYm GmbH is a biopharmaceutical company developing novel cancer immunotherapies
Investors:
we tracked 13 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 260.69M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to CatalYm
Name | Criteria | |
---|---|---|
![]() |
InnovaFeed SAS
70%
|
|
![]() |
Memo Therapeutics
70%
|
|
![]() |
Peptone
70%
|
|
![]() |
Salvia BioElectronics
70%
|
|
![]() |
Sarcura
70%
|
|
![]() |
Synendos Therapeutics
70%
|
|
![]() |
Cytoki Pharma
70%
|
|
![]() |
Eyevensys
70%
|
|
![]() |
Mestag Therapeutics
70%
|
|
![]() |
Emergence Therapeutics
70%
|
|